Biopeptek Pharmaceuticals
Mr. Chongjie Wang joined the company in 2016, bringing more than 10 years of expertise in investment banking industry. Chongjie joined MLB from Industrial And Commercial Bank of China, where he spent 7 years in a variety of leadership roles, including investment manager and risk management director. In this role, he is responsible for accounting, finance, treasury, investor relations, and equity raises. Mr. Wang holds a B.A. from Ocean University of China.
This person is not in any offices
Biopeptek Pharmaceuticals
Biopeptek Pharmaceuticals offers synthesis from small-scale research peptides to cGMP peptide APIs manufacturing.